MétaCan
Menu
Retour à la cohorte
Enregistrement W3174003681 · doi:10.1016/s2214-109x(21)00218-7

Global burden of acute lower respiratory infection associated with human parainfluenza virus in children younger than 5 years for 2018: a systematic review and meta-analysis

2021· review· en· W3174003681 sur OpenAlexaboutno aff
Xin Wang, You Li, Maria Deloria Knoll, Shabir A. Madhi, Cheryl Cohen, Vina Lea Arguelles, Sudha Basnet, Quique Bassat, W. Abdullah Brooks, Marcela Echavarría, Rodrigo Fasce, Ángela Gentile, Doli Goswami, Nusrat Homaira, Stephen R. C. Howie, Karen L. Kotloff, Najwa Khuri‐Bulos, Anand Krishnan, Marilla Lucero, Socorro Lupisan, Maria Mathisen, Kenneth A McLean, Ainara Mira‐Iglesias, Cinta Moraleda, Michiko Okamoto, Histoshi Oshitani, Katherine L. O’Brien, Betty E. Owor, Zeba Rasmussen, Barbara Rath, Vahid Salimi, Pongpun Sawatwong, J. Anthony G. Scott, Eric A. F. Simões, Viviana Sotomayor, Donald M. Thea, Florette K. Treurnicht, Lay‐Myint Yoshida, Heather J. Zar, Harry Campbell, Harish Nair

Notice bibliographique

RevueThe Lancet Global Health · 2021
Typereview
Langueen
DomaineMedicine
ThématiqueRespiratory viral infections research
Établissements canadiensnon disponible
Organismes subventionnairesFogarty International CenterMedical Research CouncilJohns Hopkins Bloomberg School of Public HealthInnovative Medicines InitiativeChina Scholarship CouncilGovernment of the United KingdomUniversity of New South WalesNational Institute for Health and Care ResearchUniversitetet i BergenTribhuvan UniversityUniversitat de BarcelonaNational Research FoundationHorizon 2020International Centre for Diarrhoeal Disease Research, BangladeshEuropean Federation of Pharmaceutical Industries and AssociationsUniversity of JordanJapan Agency for Medical Research and DevelopmentUniversité Mohammed V de RabatAstraZenecaCidara TherapeuticsWellcome TrustNational Institutes of HealthRegeneron PharmaceuticalsCenters for Disease Control and PreventionInstitució Catalana de Recerca i Estudis AvançatsAlereSanofiGlaxoSmithKlineTehran University of Medical Sciences and Health ServicesGAVI AllianceBill and Melinda Gates FoundationJohns Hopkins UniversityPfizerNovavaxU.S. Department of Health and Human Services
Mots-clésMeta-analysisMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINE2019-20 coronavirus outbreakHuman Parainfluenza VirusVirologyRespiratory systemVirusIntensive care medicinePediatricsInternal medicineBiologyDisease

Résumé

récupéré en direct d'OpenAlex

BACKGROUND: Human parainfluenza virus (hPIV) is a common virus in childhood acute lower respiratory infections (ALRI). However, no estimates have been made to quantify the global burden of hPIV in childhood ALRI. We aimed to estimate the global and regional hPIV-associated and hPIV-attributable ALRI incidence, hospital admissions, and mortality for children younger than 5 years and stratified by 0-5 months, 6-11 months, and 12-59 months of age. METHODS: We did a systematic review of hPIV-associated ALRI burden studies published between Jan 1, 1995, and Dec 31, 2020, found in MEDLINE, Embase, Global Health, Cumulative Index to Nursing and Allied Health Literature, Web of Science, Global Health Library, three Chinese databases, and Google search, and also identified a further 41 high-quality unpublished studies through an international research network. We included studies reporting community incidence of ALRI with laboratory-confirmed hPIV; hospital admission rates of ALRI or ALRI with hypoxaemia in children with laboratory-confirmed hPIV; proportions of patients with ALRI admitted to hospital with laboratory-confirmed hPIV; or in-hospital case-fatality ratios (hCFRs) of ALRI with laboratory-confirmed hPIV. We used a modified Newcastle-Ottawa Scale to assess risk of bias. We analysed incidence, hospital admission rates, and hCFRs of hPIV-associated ALRI using a generalised linear mixed model. Adjustment was made to account for the non-detection of hPIV-4. We estimated hPIV-associated ALRI cases, hospital admissions, and in-hospital deaths using adjusted incidence, hospital admission rates, and hCFRs. We estimated the overall hPIV-associated ALRI mortality (both in-hospital and out-hospital mortality) on the basis of the number of in-hospital deaths and care-seeking for child pneumonia. We estimated hPIV-attributable ALRI burden by accounting for attributable fractions for hPIV in laboratory-confirmed hPIV cases and deaths. Sensitivity analyses were done to validate the estimates of overall hPIV-associated ALRI mortality and hPIV-attributable ALRI mortality. The systematic review protocol was registered on PROSPERO (CRD42019148570). FINDINGS: 203 studies were identified, including 162 hPIV-associated ALRI burden studies and a further 41 high-quality unpublished studies. Globally in 2018, an estimated 18·8 million (uncertainty range 12·8-28·9) ALRI cases, 725 000 (433 000-1 260 000) ALRI hospital admissions, and 34 400 (16 400-73 800) ALRI deaths were attributable to hPIVs among children younger than 5 years. The age-stratified and region-stratified analyses suggested that about 61% (35% for infants aged 0-5 months and 26% for 6-11 months) of the hospital admissions and 66% (42% for infants aged 0-5 months and 24% for 6-11 months) of the in-hospital deaths were in infants, and 70% of the in-hospital deaths were in low-income and lower-middle-income countries. Between 73% and 100% (varying by outcome) of the data had a low risk in study design; the proportion was 46-65% for the adjustment for health-care use, 59-77% for patient groups excluded, 54-93% for case definition, 42-93% for sampling strategy, and 67-77% for test methods. Heterogeneity in estimates was found between studies for each outcome. INTERPRETATION: We report the first global burden estimates of hPIV-associated and hPIV-attributable ALRI in young children. Globally, approximately 13% of ALRI cases, 4-14% of ALRI hospital admissions, and 4% of childhood ALRI mortality were attributable to hPIV. These numbers indicate a potentially notable burden of hPIV in ALRI morbidity and mortality in young children. These estimates should encourage and inform investment to accelerate the development of targeted interventions. FUNDING: Bill & Melinda Gates Foundation.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,004
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesMéta-épidémiologie (sens strict)
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Méta-analyse · Signal consensuel: aucune
GenreSignal candidat: Synthèse · Signal consensuel: Synthèse
Score de désaccord entre enseignants0,542
Score d'incertitude au seuil1,000

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0040,000
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0110,001
Bibliométrie0,0000,003
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,174
Tête enseignante GPT0,492
Écart entre enseignants0,318 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Devis d'étudeMéta-analyse
Domainenon disponible
GenreSynthèse

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations100
Publié2021
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueThe Lancet Global HealthMême sujetRespiratory viral infections researchTravaux en français237 207